Panbela Therapeutics, Inc. (PBLA) Tops Q1 EPS by 132c
Tweet
Share
E-mailGet Alerts PBLA Hot Sheet
Join SI Premium – FREE
Panbela Therapeutics, Inc. (NASDAQ: PBLA) reported Q1 EPS of ($2.28), $1.32 better than the analyst estimate of ($3.60).
For earnings history and earnings-related data on Panbela Therapeutics, Inc. (PBLA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
- Morgan Stanley Upgrades Mitsubishi Chemical Holdings (4188:JP) (MTLHY) to Overweight
- RBC Capital Resumes BorgWarner (BWA) at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
